BTT-266

CAS No. 2413939-89-4

BTT-266( —— )

Catalog No. M28487 CAS No. 2413939-89-4

BTT-266 is a blocker of voltage-gated calcium channel for pain management.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 372 In Stock
5MG 249 In Stock
10MG 373 In Stock
25MG 657 In Stock
50MG 986 In Stock
100MG 1479 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    BTT-266
  • Note
    Research use only, not for human use.
  • Brief Description
    BTT-266 is a blocker of voltage-gated calcium channel for pain management.
  • Description
    BTT-266 is a blocker of voltage-gated calcium channel for pain management.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    Calcium Channel
  • Recptor
    PKC
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2413939-89-4
  • Formula Weight
    556.61
  • Molecular Formula
    C34H28N4O4
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    COC1=CC=C(C2=NN(C(=O)C3=CC(C(=O)O)=CC=C3)C(C3=CN(C4=CC=CC=C4)N=C3C3=CC=C(C)C=C3)C2)C=C1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • TROX-1

    A potent, state-dependent blocker of Cav2 channels that preferentially inhibits potassium-triggered calcium influx through recombinant Cav2.2 under depolarized conditions with IC50 of 0.27 uM.

  • Tiapamil hydrochlori...

    Tiapamil hydrochloride (Ro 11-1781 hydrochloride) is a calcium channel blocker with antihypertensive activity and may be used in the study of angina and cardiovascular disease.

  • SR33805

    SR33805 is a potent antagonist of Ca2+ channel(EC50s of 4.1 nM and 33 nM in depolarized and polarized conditions, respectively)Acute treatment with SR33805 restored the MI-altered cell shortening without affecting the Ca(2+) transient amplitude, suggesting an increase of myofilament Ca(2+) sensitivity in MI myocytes.?